Navigation Links
Salix Pharmaceuticals Previews Digestive Disease Week 2007

RALEIGH, N.C.--(BUSINESS WIRE)--May 17, 2007 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that results of 18 investigator-initiated trials related to the Company's products will be presented at Digestive Disease Week(R) 2007, which will be held May 19-24, 2007. Digestive Disease Week is considered the largest and most prestigious meeting in the world for the GI professional. Every year it attracts more than 16,000 physicians, researchers and academics from around the world who desire to stay up-to-date in their respective fields. The meeting is the year's best opportunity to learn about the latest advances in gastroenterology, hepatology, endoscopy and gastrointestinal surgery; prevention, diagnosis and treatment of digestive disorders; and cutting-edge technological advances.

POSTER PRESENTATIONS: -0-

TOPIC                                        LEAD AUTHOR        DATE

---------------------------------------- -------------------- --------


XIFAXAN

An open label series of rifaximin for     A. Kornbluth, M.D.   May 20

 long term maintenance therapy for

 patients with refractory pouchitis


History of hypothyroidism is associated   E. Lauritano, M.D.   May 20

 to small intestinal bacterial

 overgrowth


High dosage rifaximin for the treatment  E. Scarpellini, M.D.  May 20

 of small intestinal overgrowth


High recurrence of small intestinal       E. Lauritano, M.D.   May 20

 bacterial overgrowth after antibiotic


Rifaximin versus systemic antibiotics     M. Gabrelli, M.D.    May 20

 for the treatment of small bowel

 bacterial overgrowth


Small intestinal bacterial overgrowth in   A. Parodi, M.D.     May 20

 acromegalic patients


May breath test be useful in diagnosis     A. Parodi, M.D.     May 20

 of IBS patients? an Italian Study


The oral nonsystemic antibiotic            H. DuPont, M.D.     May 20

 rifaximin prevents symptom recurrence

 in patients with recurrent C.

 difficile-associated diarrhea


Characterization o
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salix Pharmaceuticals Previews Digestive Disease Week
(Date:11/27/2009)... 27 ACUO TECHNOLOGIES, developers ...are, data migration tools and services, is pleased...demark Office has approved a patent application fo... Network." Acuo Technologies is pleased to add the...erty. In general, the granted patent application b...
(Date:11/26/2009)...ov.26/PRNewswire/--The2009Frost&SullivanSouthA...alMarketispresentedtoCiplaMedproSouthAfricaLimited.../20081117/FSLOGO ) ,, FortheCompanyoftheYearAwa...pro,sperformanceagainstkeycompetitors:growthstrate...ocesses,productsand/ortechnologiesandleadershipinc...
(Date:11/25/2009)...v. 25 American Scientifi...") is pleased to announce that they have opened a ...e in Shanghai, China. ,, ASR has been able to s...teway for the development and production of curren...en and adults to be distributed and sold globally....
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3American Scientific Resources Inc. Opens Shanghai Location 2WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders 5569 1WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders 5569 2FDA Approves New Treatment for Advanced Form of Kidney Cancer 5565 1FDA Approves New Treatment for Advanced Form of Kidney Cancer 5565 2PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 1PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 2PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 3
...al potential in independent study ... Md., Aug. 21 Israeli et al.,* in an article,just...splantation, have,further developed our understand...mediated immunity in pediatric liver-transplant pa...ative group involving several institutions in,Peta...
...ief plaster,(Versatis) is now approved by the Scot... within NHS Scotland for patients suffering pain f....org.uk/smc/5850.html . This,reversal of the previ...satis (5% lidocaine medicated plaster) is based on...omparative data and brings prescribing,availabilit...
Other Medicine Technology:New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients 2New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients 3Shingles Pain Treatment Will Benefit More Patients 2Shingles Pain Treatment Will Benefit More Patients 3Shingles Pain Treatment Will Benefit More Patients 4
(Date:11/26/2009)...ng drug tetrathiomolybdate (TM) has been shown in ... disease, a disease caused by an overload of coppe...own. Very little, however, is known about how the ... led by Northwestern University researchers now ha...al structure of TM bound to copper-loaded metalloc...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, a ... is one of a growing number of physicians who are ...es to connect with individuals who are interested ...obesity. Dr. Kim is utilizing Facebook to share be...actice with the community. , ...
(Date:11/25/2009)...., Nov. 25 When most pe...tist. But a chiropractor can also give patients t...dibular Joint, which is where your jaw (mandible) ... ,, The most common symptoms associated with T...popping of the jaw. But many other symptoms can b...
(Date:11/25/2009)...v. 25 /PRNewswire/ - Sentinelle Medical Inc., a le...d visualization software launches a suite of new l... medical imaging software platform at this year,s ...l meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Boot...que high quality images generated by Sentinelle,s ...
(Date:11/25/2009)...SCO, Nov. 25 The Bay Area Air Qual...rst Winter Spare the Air Alert ...g wood, manufactured firelogs or any other solid f... weather will contribute to unhealthy air quality ...of the Air District. "We,re asking Bay Area reside...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
... Will Teach an Innovative Educational Event on the...n Tuesday, November 18th at 8:30 PM EST; then will...e afterwards , Washington...e series on treating depression with proven, natur...
...to address the Joint Commissi...Med Healthcare Management,announced today the resu...sfaction Survey. The independent review organizati...in size from,fewer than 100 beds to more than 500,...
...ent Corporation (NYSE: GTS ), the largest managed...rd consolidated revenues for the three,months ende...or $0.29 per,diluted share, includes an after tax ...of Directors has authorized the,repurchase of up t...
...ation,introduces Manicures and Martinis, a new and... women together in a casual setting over manicures...of preserving fertility. It,s,free, relaxing, fun,...e Grifo, MD, Ph.D., of NYU School of Medicine., T...
...ing Metabolic Projects,Available for Partnering-, ...on (NASDAQ: GENR ) will present at the Windhover,...eld November 3-5 at the Lowes Hotel in,Philadelphi...e 2 diabetes and obesity on Tuesday, November 4, 2...
...- Nuvo Research Inc.,(TSX: NRI), a Canadian drug d...elopment of drug products that are delivered to an...al drug delivery technologies, today,announced its... target to resubmit its Pennsaid application to ...
Other Medicine News:Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 2Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 3Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 4Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 5Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 6Health News:AllMed Announces Annual Hospital Peer Review Survey Results 2Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 2Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 3Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 4Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 5Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 6Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 7Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 8Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 9Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 10Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 11Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 12Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 13Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 14Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 15Health News:Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million 16Health News:The American Fertility Association Announces Plan to Help Young Women Preserve Fertility 2Health News:Genaera to Present at Therapeutic Area Partnerships 2008 2Health News:NUVO announces third quarter 2008 financial results 2Health News:NUVO announces third quarter 2008 financial results 3Health News:NUVO announces third quarter 2008 financial results 4Health News:NUVO announces third quarter 2008 financial results 5Health News:NUVO announces third quarter 2008 financial results 6Health News:NUVO announces third quarter 2008 financial results 7Health News:NUVO announces third quarter 2008 financial results 8Health News:NUVO announces third quarter 2008 financial results 9Health News:NUVO announces third quarter 2008 financial results 10Health News:NUVO announces third quarter 2008 financial results 11Health News:NUVO announces third quarter 2008 financial results 12Health News:NUVO announces third quarter 2008 financial results 13
Heidelberg Multi Color (HMC) Anomaloscope
...s new Infiniti Vision System is the worlds first t...s single instrument now allows surgeons to,choos...t. The Infiniti Vision System features revolutiona...ptions using the new AquaLase Liquefaction Device,...
...ice seamlessly integrates practice management and ...d clinical workflow. Instantly access registration...porting information for multiple practices, provid...ely improves productivity by simplifying office wo...
Centricity Physician Office Practice Management
Medicine Products: